The MED13L haploinsufficiency syndrome associated with de novo nonsense variant (P.GLN1981*)

1Asadollahi R, Oneda B, Sheth F, Azzarello-Burri S, Baldinger R, Joset P, et al. Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability. Eur J Hum Genet. 2013;21(10):1100–1104. doi: 10.1038/ ejhg.2013.17 Asadollahi R Oneda B Sheth F Azzarello-Burri S Baldinger R Joset P et al Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability Eur J Hum Genet 2013 21(10) 1100 1104 10.1038/ejhg.2013.17Open DOISearch in Google Scholar

2Deciphering Developmental Disorders Study. Prevalence and architecture of de novo mutations in developmental disorders. Nature. 2017;542(7642):433–8. doi: 10.1038/nature21062 Deciphering Developmental Disorders Study. Prevalence and architecture of de novo mutations in developmental disorders Nature 2017 542(7642) 433–8 10.1038/nature21062Open DOISearch in Google Scholar

3Muncke N, Jung C, Rüdiger H, Ulmer H, Roeth R, Hubert A, et al. Missense mutations and gene interruption in PROSIT240, a novel TRAP240-like gene, in patients with congenital heart defect (transposition of the great arteries). Circulation. 2003;108(23):2843–50. doi: 10.1161/01.CIR.0000103684.77636.CD Muncke N Jung C Rüdiger H Ulmer H Roeth R Hubert A et al Missense mutations and gene interruption in PROSIT240, a novel TRAP240-like gene, in patients with congenital heart defect (transposition of the great arteries) Circulation 2003 108(23) 2843–50 10.1161/01.CIR.0000103684.77636.CDOpen DOISearch in Google Scholar

4Smol T, Petit F, Piton A, Keren B, Sanlaville D, Afenjar A, et al. MED13L-related intellectual disability: involvement of missense variants and delineation of the phenotype. Neurogenetics. 2018;19(2):93–103. doi: 10.1007/s10048-018-0541-0 Smol T Petit F Piton A Keren B Sanlaville D Afenjar A et al MED13L-related intellectual disability: involvement of missense variants and delineation of the phenotype. Neurogenetics 2018 19(2) 93 103 10.1007/s10048-018-0541-0Open DOISearch in Google Scholar

5Tørring PM, Larsen MJ, Brasch-Andersen C, Krogh LN, Kibæk M, Laulund L, et al. Is MED13L-related intellectual disability a recognizable syndrome? Eur J Med Genet. 2019;62(2):129–36. doi: 10.1016/j.ejmg.2018.06.014 Tørring PM Larsen MJ Brasch-Andersen C Krogh LN Kibæk M Laulund L et al Is MED13L-related intellectual disability a recognizable syndrome? Eur J Med Genet 2019 62(2) 129–36 10.1016/j.ejmg.2018.06.014Open DOISearch in Google Scholar

6Adegbola A, Musante L, Callewaert B, Maciel P, Hu H, Isidor B, et al. Redefining the MED13L syndrome. Eur J Hum Genet. 2015;23(10):1308–17. doi: 10.1038/ejhg.2015.26 Adegbola A Musante L Callewaert B Maciel P Hu H Isidor B et al Redefining the MED13L syndrome. Eur J Hum Genet 2015 23(10) 1308–17 10.1038/ejhg.2015.26Open DOISearch in Google Scholar

7Asadollahi R, Zweier M, Gogoll L, Schifmann R, Sticht H, Steindl K, et al. Genotype-phenotype evaluation of MED13L defects in the light of a novel truncating and a recurrent missense mutation. Eur J Med Genet. 2017;60(9):451–64. doi: 10.1016/j. ejmg.2017.06.004 Asadollahi R Zweier M Gogoll L Schifmann R Sticht H Steindl K et al Genotype-phenotype evaluation of MED13L defects in the light of a novel truncating and a recurrent missense mutation. Eur J Med Genet 2017 60(9) 451–64 10.1016/j.ejmg.2017.06.004Open DOISearch in Google Scholar